In India, diabetes mellitus is on the rise at an alarming rate: A review

Arnab Bagchi; Prosanta Pal

doi:10.18231/j.joapr.2021.01.05

Authors

Arnab Bagchi Himalyan Pharmacy Institute, Department of Pharmaceutics, Rangpo, Sikkim
Prosanta Pal University of North Bengal, Department of Pharmaceutical Technology, Siliguri West Bengal

DOI:

https://doi.org/10.18231/j.joapr.2021.01.05

Keywords:

Diabetes, Hypertention, Cholesterol, WHO, NHANES

Abstract

The aim of the current review is to acquaint all the covering aspect of dibetes mellitus which can provide awareness to the diabetes patients in india as well as all over the world. The number of diabetic patients in india is increasing at an alarming rate and is therefore a major area for concern. As per the WHO, the diabetes is expected to reach 79.4 million by 2030. The studies have shown that the type II diabetes is 4-6 times higher in urban than in rural areas in india. Development of diabetes among indians is due to several factors such as age ( Based on NHANES data),waist circumference, hypertention, BMI, smoking habit and total cholestero these variables are important for comparing diabetic and non-diabetic patients

Downloads

Download data is not yet available.

References

Abdulfatai BO, Olusegun AO, Lateefat BO. Type 2 diabetes mellitus; a review of current trends. Oman.Med.S.B, 27(4), 269-273(2012)

Mehmet EO, Ioannis DK, Panoraia IS. Diabetes mellitus: a review on pathophysiology, current status of oral medications and future perspectives. Acta.Pharm.Sci, 55(1),61-77 (2017)

Ozougwu JC, Obima KC, Belonwu CD, Unakalamba CB. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J.P.A.P, 4(4),46-57(2013);

Ritu L. The history of diabetes mellitus. Sultan. Qaboos. University. Med.J, 13(3),368-370 (2013)

Mark AA, George SE, Aaron WM. Type 1 diabetes. The lancet, 383(991),69-82 (2014)

Vanesa B, Lazaros B, Ioanna T, Evangelos E. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analysis. Plos one, 13(3), 1-27 (2018)

Suzanne MDLK and Jack RW. Alzheimer’s disease is type 3 diabetes-evidence reviewed. J. Diabetes. Sci. Technol, 2(6), 1101-1113 (2008)

Viroj W. Diabetes type 4: a new unnamed diabetes mellitus type 4. J. Clin. Diabetes, 1(1), 102 (2017)

Satyender K, Deepika P, Parijat P, Neeta. Herbal drugs used in the treatment of diabetes: an overview. World. J. Pharmacy. Pharmaceutical .Sci, 6(9), 697-708 (2017)

Habtamu WB. Classification, pathophysiology, diagnosis and management of diabetes mellitus. J.Diabetes.Metab, 6(5), 1-9 (2015)

Francesco Z, David RW, Thomas Y, Melanie JD. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90 year perspective.J.M.A.J, 92(108), 697-708 (2016)

Kohei K. Pathophysiology of type 2 diabetes and its treatment policy. J.M.A.J, 53(1), 4-46 (2010)

Jomana K. Double or hybride diabetes: a system review on disease prevalence, characteristics and risk factors. Nutrition. And Diabetes, 9(33), 1-9 (2019)

Akula S, Akula S, Thota S. Prevalence of diabetes mellitus and its risk factors. I.A.I.M, 6(3), 319-324 (2019)

Poornima MP, Padmaja RW. Prevalence of type of diabetes mellitus among adults aged between 30 to 60 years residing in rural area: a cross sectional study. International. J. Community.Med.Public health, 5(8), 3639-3642 (2018)

Sonia V, Madhu G, Harvindes P, Geeta A. Diabetes mellitus treatment using herbal drug. International .J. Phytomedicine, 10(1), 1-10 (2017)

Jaya PTJST, Gursimer J, Sohan C, Sanjoy J, Arnab P, Rajendra P, Rajiv S. Prevalence and risk factors of diabetes in a large community - based study in north india: result from a STEPS survey in punjab, india. Diabetol. Metab. Syndr, 9(8), 1-8 ( 2017)

Li CN, Manish G. Transdermal drug delivery system in diabetes management: a review. Asian. J. Pharm. Sci, 22(12), 1-13 (2019)

Yingzheng Z, Guangcul X, Weidong W, Xianwen Y. Type 2 diabetes mellitus - diseases, diagnosis and treatment. J. Diabetes. Metab, 6(5), 1-6 (2015)

Manish M, Priyanjali D, Jayant L, Saroj G, Thomas PA, Devasagayam. Indian herbs and herbal drugs used for the treatment of diabetes. J.Clin.Biochem.Nutr, 40(3), 163-173 (2007)

Gharravi AM, Jafar A, Ebrahimi M, Mahmodi A, Pourhashemi E, Haseli N, Talaie N, Hajiasgarli P. Current status of stem cell therapy, scaffolds for the treatment of diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 12(6), 1133-1139 (2018)

Khalil H. Diabetes microvascular complications—A clinical update. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11(2), 33-39 (2017)

Abdulah DM, Hassan AB, Saadi FS, Mohammed AH. Impacts of self-management education on glycaemic control in patients with type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 12(6), 969-975 (2018)

Gupta A, Jelinek HF, Al-Aubaidy H. Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11(3), 225-230 (2017)

Tiwari P. Recent trends in therapeutic approaches for diabetes management: a comprehensive update. Journal of diabetes research, 10(4), 11-15 (2015)

Jaén ML, Vilà L, Elias I, Jimenez V, Rodó J, Maggioni L, Ruiz-de Gopegui R, Garcia M, Muñoz S, Callejas D, Ayuso E. Long-term efficacy and safety of insulin and glucokinase gene therapy for diabetes: 8-year follow-up in dogs. Molecular therapy-methods & clinical development, 15(7), 1-7 (2017)

Sahoo K, Sahoo B, Choudhury AK, Sofi NY, Kumar R, Bhadoria AS. Childhood obesity: causes and consequences. Journal of family medicine and primary care, 4(2), 187-193 (2015)

Yang LJ. Big mac attack: does it play a direct role for monocytes/macrophages in type 1 diabetes?. Diabetes, 57(11), 2922-2923 (2008)

Mas A, Montané J, Anguela XM, Muñoz S, Douar AM, Riu E, Otaegui P, Bosch F. Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle. Diabetes, 55(6), 1546-1553 (2006)

Montane J, Cadavez L, Novials A. Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes. Diabetes, metabolic syndrome and obesity: targets and therapy, 7(6), 25-31 (2014)

Handorf AM, Sollinger HW, Alam T. Genetic engineering of surrogate β cells for treatment of type 1 diabetes mellitus. Journal of Diabetes Mellitus, 5(4), 295-298 (2015)

Yoon JW, Jun HS. Recent advances in insulin gene therapy for type 1 diabetes. Trends in molecular medicine, 8(2), 62-68 (2002)

Calne RY, Gan SU, Lee KO. Stem cell and gene therapies for diabetes mellitus. Nature Reviews Endocrinology, 6(3), 173-177 (2010)

Migliorini A, Bader E, Lickert H. Islet cell plasticity and regeneration. Molecular metabolism, 3(3), 268-274 (2014)

Aguayo-Mazzucato C, Bonner-Weir S. Pancreatic β cell regeneration as a possible therapy for diabetes. Cell metabolism, 27(1), 57-67 (2018)

Xu X, Ren J. Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity. International journal of obesity, 39(3), 387-396 (2015)

Wong MS, Hawthorne WJ, Manolios N. Gene therapy in diabetes. Self/nonself, 1(3), 165-175 (2010)

Tudurí E, Bruin JE, Kieffer TJ. Restoring insulin production for type 1 diabetes. Journal of diabetes, 4(4), 319-331(2012)

Dassaye R, Naidoo S, Cerf ME. Transcription factor regulation of pancreatic organogenesis, differentiation and maturation. Islets, 8(1), 13-34 (2016)